vs
LIFECORE BIOMEDICAL, INC. \DE\（LFCR）与REGIS CORP（RGS）财务数据对比。点击上方公司名可切换其他公司
REGIS CORP的季度营收约是LIFECORE BIOMEDICAL, INC. \DE\的1.8倍（$57.1M vs $31.1M），REGIS CORP净利率更高（0.8% vs -32.1%，领先32.9%），REGIS CORP同比增速更快（22.3% vs -4.5%），REGIS CORP自由现金流更多（$891.0K vs $25.0K），过去两年REGIS CORP的营收复合增速更高（7.8% vs -0.1%）
LIFECORE BIOMEDICAL, INC.是一家生物医药企业，专注于研发和生产以透明质酸为主的高品质生物材料，业务覆盖医疗应用产品、制药解决方案、个人护理原料三大核心板块，主要市场遍布北美、欧洲、亚太地区，服务头部医疗器械、制药、美妆品牌客户。
瑞吉斯公司是一家美国美发沙龙运营商，总部位于明尼苏达州明尼阿波利斯市。截至2021年8月，该集团旗下拥有5563家加盟沙龙以及276家直营门店，是北美地区规模领先的美发沙龙连锁经营企业。
LFCR vs RGS — 直观对比
营收规模更大
RGS
是对方的1.8倍
$31.1M
营收增速更快
RGS
高出26.7%
-4.5%
净利率更高
RGS
高出32.9%
-32.1%
自由现金流更多
RGS
多$866.0K
$25.0K
两年增速更快
RGS
近两年复合增速
-0.1%
损益表 — Q2 FY2026 vs Q2 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $31.1M | $57.1M |
| 净利润 | $-10.0M | $456.0K |
| 毛利率 | 25.0% | — |
| 营业利润率 | -9.9% | 10.8% |
| 净利率 | -32.1% | 0.8% |
| 营收同比 | -4.5% | 22.3% |
| 净利润同比 | -52.0% | -94.0% |
| 每股收益（稀释后） | $-0.29 | $0.16 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收LFCRRGS
| Q4 25 | — | $57.1M | ||
| Q3 25 | $31.1M | $59.0M | ||
| Q2 25 | — | $60.4M | ||
| Q1 25 | $35.2M | $57.0M | ||
| Q4 24 | $32.6M | $46.7M | ||
| Q3 24 | $24.7M | $46.1M | ||
| Q2 24 | — | $49.4M | ||
| Q1 24 | $35.7M | $49.2M |
净利润LFCRRGS
| Q4 25 | — | $456.0K | ||
| Q3 25 | $-10.0M | $1.4M | ||
| Q2 25 | — | $116.5M | ||
| Q1 25 | $-14.8M | $250.0K | ||
| Q4 24 | $-6.6M | $7.6M | ||
| Q3 24 | $-16.2M | $-853.0K | ||
| Q2 24 | — | $91.2M | ||
| Q1 24 | $15.6M | $-2.3M |
毛利率LFCRRGS
| Q4 25 | — | — | ||
| Q3 25 | 25.0% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 28.0% | — | ||
| Q4 24 | 34.0% | — | ||
| Q3 24 | 21.8% | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 33.3% | — |
营业利润率LFCRRGS
| Q4 25 | — | 10.8% | ||
| Q3 25 | -9.9% | 10.0% | ||
| Q2 25 | — | 12.1% | ||
| Q1 25 | -25.7% | 8.8% | ||
| Q4 24 | -6.0% | 11.8% | ||
| Q3 24 | -46.9% | 4.6% | ||
| Q2 24 | — | — | ||
| Q1 24 | -2.5% | 8.3% |
净利率LFCRRGS
| Q4 25 | — | 0.8% | ||
| Q3 25 | -32.1% | 2.3% | ||
| Q2 25 | — | 192.9% | ||
| Q1 25 | -42.0% | 0.4% | ||
| Q4 24 | -20.2% | 16.4% | ||
| Q3 24 | -65.7% | -1.9% | ||
| Q2 24 | — | 184.7% | ||
| Q1 24 | 43.8% | -4.7% |
每股收益（稀释后）LFCRRGS
| Q4 25 | — | $0.16 | ||
| Q3 25 | $-0.29 | $0.49 | ||
| Q2 25 | — | $43.67 | ||
| Q1 25 | $-0.47 | $0.08 | ||
| Q4 24 | $-0.25 | $2.71 | ||
| Q3 24 | $-0.53 | $-0.36 | ||
| Q2 24 | — | $38.40 | ||
| Q1 24 | $0.42 | $-1.00 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $18.9M | $18.4M |
| 总债务越低越好 | $136.0M | $113.3M |
| 股东权益账面价值 | $-10.5M | $188.7M |
| 总资产 | $235.2M | $588.3M |
| 负债/权益比越低杠杆越低 | — | 0.60× |
8季度趋势，按日历期对齐
现金及短期投资LFCRRGS
| Q4 25 | — | $18.4M | ||
| Q3 25 | $18.9M | $16.6M | ||
| Q2 25 | — | $17.0M | ||
| Q1 25 | $5.4M | $13.3M | ||
| Q4 24 | $9.5M | $10.2M | ||
| Q3 24 | — | $6.3M | ||
| Q2 24 | — | $10.1M | ||
| Q1 24 | — | $5.9M |
总债务LFCRRGS
| Q4 25 | — | $113.3M | ||
| Q3 25 | $136.0M | $111.3M | ||
| Q2 25 | — | $110.8M | ||
| Q1 25 | $124.9M | $112.0M | ||
| Q4 24 | $111.3M | $111.5M | ||
| Q3 24 | $106.3M | $95.2M | ||
| Q2 24 | — | $99.5M | ||
| Q1 24 | $97.1M | $179.7M |
股东权益LFCRRGS
| Q4 25 | — | $188.7M | ||
| Q3 25 | $-10.5M | $187.6M | ||
| Q2 25 | — | $185.6M | ||
| Q1 25 | $2.2M | $68.6M | ||
| Q4 24 | $15.4M | $66.7M | ||
| Q3 24 | $-3.9M | $56.4M | ||
| Q2 24 | — | $56.8M | ||
| Q1 24 | $17.7M | $-35.8M |
总资产LFCRRGS
| Q4 25 | — | $588.3M | ||
| Q3 25 | $235.2M | $592.1M | ||
| Q2 25 | — | $599.0M | ||
| Q1 25 | $237.7M | $511.2M | ||
| Q4 24 | $255.4M | $530.1M | ||
| Q3 24 | $246.8M | $508.9M | ||
| Q2 24 | — | $530.5M | ||
| Q1 24 | $246.2M | $543.7M |
负债/权益比LFCRRGS
| Q4 25 | — | 0.60× | ||
| Q3 25 | — | 0.59× | ||
| Q2 25 | — | 0.60× | ||
| Q1 25 | 56.05× | 1.63× | ||
| Q4 24 | 7.20× | 1.67× | ||
| Q3 24 | — | 1.69× | ||
| Q2 24 | — | 1.75× | ||
| Q1 24 | 5.49× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $1.8M | $1.7M |
| 自由现金流经营现金流 - 资本支出 | $25.0K | $891.0K |
| 自由现金流率自由现金流/营收 | 0.1% | 1.6% |
| 资本支出强度资本支出/营收 | 5.6% | 1.4% |
| 现金转化率经营现金流/净利润 | — | 3.65× |
| 过去12个月自由现金流最近4个季度 | $-16.8M | $14.9M |
8季度趋势，按日历期对齐
经营现金流LFCRRGS
| Q4 25 | — | $1.7M | ||
| Q3 25 | $1.8M | $2.3M | ||
| Q2 25 | — | $6.8M | ||
| Q1 25 | $1.2M | $6.2M | ||
| Q4 24 | $-6.1M | $2.1M | ||
| Q3 24 | $-613.0K | $-1.3M | ||
| Q2 24 | — | $5.1M | ||
| Q1 24 | $-1.4M | $-277.0K |
自由现金流LFCRRGS
| Q4 25 | — | $891.0K | ||
| Q3 25 | $25.0K | $1.9M | ||
| Q2 25 | — | $6.2M | ||
| Q1 25 | $-4.3M | $5.9M | ||
| Q4 24 | $-8.6M | $1.7M | ||
| Q3 24 | $-4.0M | $-1.4M | ||
| Q2 24 | — | $5.1M | ||
| Q1 24 | $-7.8M | $-326.0K |
自由现金流率LFCRRGS
| Q4 25 | — | 1.6% | ||
| Q3 25 | 0.1% | 3.2% | ||
| Q2 25 | — | 10.3% | ||
| Q1 25 | -12.1% | 10.3% | ||
| Q4 24 | -26.3% | 3.6% | ||
| Q3 24 | -16.3% | -3.0% | ||
| Q2 24 | — | 10.3% | ||
| Q1 24 | -21.8% | -0.7% |
资本支出强度LFCRRGS
| Q4 25 | — | 1.4% | ||
| Q3 25 | 5.6% | 0.7% | ||
| Q2 25 | — | 0.9% | ||
| Q1 25 | 15.5% | 0.6% | ||
| Q4 24 | 7.5% | 0.9% | ||
| Q3 24 | 13.9% | 0.0% | ||
| Q2 24 | — | 0.0% | ||
| Q1 24 | 17.8% | 0.1% |
现金转化率LFCRRGS
| Q4 25 | — | 3.65× | ||
| Q3 25 | — | 1.68× | ||
| Q2 25 | — | 0.06× | ||
| Q1 25 | — | 24.80× | ||
| Q4 24 | — | 0.28× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 0.06× | ||
| Q1 24 | -0.09× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
LFCR
| Transferred At Point In Time | $26.6M | 85% |
| Transferred Over Time | $4.5M | 15% |
RGS
| Franchise Segment | $37.9M | 66% |
| Royalty | $13.6M | 24% |
| Other | $2.8M | 5% |
| Fees | $1.8M | 3% |
| Franchise Fees | $1.0M | 2% |
